1. Home
  2. FMST vs MYO Comparison

FMST vs MYO Comparison

Compare FMST & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foremost Lithium Resource & Technology Ltd.

FMST

Foremost Lithium Resource & Technology Ltd.

HOLD

Current Price

$2.28

Market Cap

32.9M

ML Signal

HOLD

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$0.77

Market Cap

36.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMST
MYO
Founded
2005
2004
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Industrial Specialties
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.9M
36.9M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
FMST
MYO
Price
$2.28
$0.77
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
209.5K
443.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.86
EPS
N/A
N/A
Revenue
N/A
$1,000,000,000.00
Revenue This Year
N/A
$24.07
Revenue Next Year
N/A
$17.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40814.79
52 Week Low
$0.55
$0.64
52 Week High
$5.74
$6.27

Technical Indicators

Market Signals
Indicator
FMST
MYO
Relative Strength Index (RSI) 52.58 45.77
Support Level $2.10 $0.74
Resistance Level $2.53 $1.03
Average True Range (ATR) 0.20 0.06
MACD 0.01 -0.00
Stochastic Oscillator 70.13 67.32

Price Performance

Historical Comparison
FMST
MYO

About FMST Foremost Lithium Resource & Technology Ltd.

Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: